Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 2;34(8):1168-1182.e6.
doi: 10.1016/j.cmet.2022.05.009. Epub 2022 Jun 14.

A mechanosensitive lipolytic factor in the bone marrow promotes osteogenesis and lymphopoiesis

Affiliations
Free article

A mechanosensitive lipolytic factor in the bone marrow promotes osteogenesis and lymphopoiesis

Hui Peng et al. Cell Metab. .
Free article

Abstract

Exercise can prevent osteoporosis and improve immune function, but the mechanism remains unclear. Here, we show that exercise promotes reticulocalbin-2 secretion from the bone marrow macrophages to initiate bone marrow fat lipolysis. Given the crucial role of lipolysis in exercise-stimulated osteogenesis and lymphopoiesis, these findings suggest that reticulocalbin-2 is a pivotal regulator of a local adipose-osteogenic/immune axis. Mechanistically, reticulocalbin-2 binds to a functional receptor complex, which is composed of neuronilin-2 and integrin beta-1, to activate a cAMP-PKA signaling pathway that mobilizes bone marrow fat via lipolysis to fuel the differentiation and function of mesenchymal and hematopoietic stem cells. Notably, the administration of recombinant reticulocalbin-2 in tail-suspended and old mice remarkably decreases bone marrow fat accumulation and promotes osteogenesis and lymphopoiesis. These findings identify reticulocalbin-2 as a novel mechanosensitive lipolytic factor in maintaining energy homeostasis in bone resident cells, and it provides a promising target for skeletal and immune health.

Keywords: bone marrow fat; bone metabolism; exercise; fat metabolism; immunity; lipolysis; reticulocalbin-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests X-H.L. and H.P. disclose that they are inventors of a submitted patent application by Xiangya Hospital of Central South University covering recombinant RCN2.

Publication types